Rafael Holdings, Inc.
Pharmaceutical company · Newark, New Jersey, United States · NYSE: RFL
Rafael Holdings, Inc. is a pharmaceutical company headquartered in Newark, New Jersey, United States. Its earliest recorded incorporation is in 2017. Its shares trade on NYSE under the ticker RFL. It has reported private securities offerings to the US SEC, most recently $104 million sold in a notice filed in 2021.
Rafael Holdings at a glance
What does Rafael Holdings do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $104.2 million sold (2021).
Frequently asked questions about Rafael Holdings
Where is Rafael Holdings headquartered?
Rafael Holdings, Inc. is headquartered in Newark, New Jersey, United States.
What does Rafael Holdings do?
Rafael Holdings, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Rafael Holdings a public company?
Yes. Rafael Holdings, Inc. trades on NYSE under the ticker RFL.
When was Rafael Holdings founded?
The earliest incorporation on record for Rafael Holdings, Inc. is in 2017, according to public company registers.
Similar companies
- Protagonist Therapeutics, IncNewark, California, United States
- Rain Oncology Inc.Newark, California, United States
- InCarda Therapeutics, Inc.Newark, California, United States
- CymaBay Therapeutics, Inc.Newark, California, United States
- Symbiomix Therapeutics, LLCNewark, New Jersey, United States
- Inergetics IncNewark, New Jersey, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences